首页 | 本学科首页   官方微博 | 高级检索  
     

临床分离非O1/O139群霍乱弧菌毒力及耐药特征分析
引用本文:周妍妍,杨伟明,李世荣,闫东辉,苏建荣. 临床分离非O1/O139群霍乱弧菌毒力及耐药特征分析[J]. 疾病监测, 2016, 31(6): 517-521. DOI: 10.3784/j.issn.1003-9961.2016.06.017
作者姓名:周妍妍  杨伟明  李世荣  闫东辉  苏建荣
作者单位:1.首都医科大学附属北京友谊医院临床检验中心, 北京 100050
基金项目:CMU (No.yyqdkt2015-23)北京市自然科学基金(No.7164249),北京友谊医院科研启动基金资助项目(No.yyqdkt2015-23)
摘    要:目的 了解临床分离的非O1/O139群霍乱弧菌毒力及耐药特征。方法 收集2014-2015年北京友谊医院4-10月肠道门诊分离到的非O1/O139群霍乱弧菌,采用微量肉汤稀释法检测霍乱弧菌对15种抗生素的耐药性;PCR检测霍乱弧菌的毒力相关基因。结果 35株非O1/O139群霍乱弧菌对复方新诺明的耐药率(40.0%)最高,其次是氯霉素(28.5%)和磺胺异恶唑(22.6%),对阿莫西林/克拉维酸、头孢曲松、头孢西丁、头孢吡肟及亚胺培南完全敏感。毒力基因检测显示所有菌株均携带hlyA和ompU,hapA(97.1%)、rtxA(91.4%)、Ⅵ型分泌系统T6SS(94.3%~97.1%)、Ⅲ型分泌系统T3SS(80.0%~85.7%)和nanH(62.9%)阳性率较高;主要的毒力基因型为hlyA-rtxA-hapA-ompU-nanH-vasA-vasK-vasH-vcsC-vcsV-vcsN-vspD(40.0%)。结论 临床分离非O1/O139群霍乱弧菌毒力基因多样化,对抗菌药物耐药性较高,需加强腹泻病例中非O1/O139群霍乱弧菌的毒力及耐药监测。

关 键 词:非O1/O139群霍乱弧菌   毒力基因   抗药性
收稿时间:2016-01-19

Characteristics of virulence gen distribution and antibiotic resistance of non-O1/O139 Vibrio cholera
Affiliation:1.Center of Clinical Laboratory, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China2.Infection Control Department, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China
Abstract:Objective To explore the distribution of virulence genes and drug resistance of non-O1/O139Vibrio (V.) cholerae. Methods Non-O1/O139V.cholerae strains and the related patient records were collected from the intestinal clinic of Beijing Friendship Hospital from 2014 to 2015. The susceptibility of V.cholerae strain to 15 antibiotics was tested with microbroth dilution method, and virulence genes were detected by using polymerase chain reaction (PCR). Results The drug susceptibility test showed that the resistant rate of 35 strains of non-O1/O139V.cholerae to trimethoprim-sulfamethoxazole was highest (40.0%), followed by the resistant rates to chloramphenicol (28.5%) and sulfisoxazole (22.6%). The strains were sensitive to amoxicillin/clavulanate, ceftriaxone, cefoxitin, cefepime and imipenem. PCR detection of virulence genes showed that all strains were positive for hlyA and ompU gene, and the positive rates of hapA, rtxA, T6SS, T3SS and nanH were 97.1%, 91.4%, 94.3%-97.1%, 80.0%-85.7%, 62.9%, respectively. The predominant virulence pattern was hlyA-rtxA-hapA-ompU-nanH-vasA-vasK-vasH-vcsC-vcsV-vcsN-vspD (40.0%). Conclusion The high antibiotic resistance and virulence gene polymorphism suggested that it is important to strengthen the surveillance for the genetic variation and drug resistance of the clinical isolates of non-O1/O139 V.cholerae.
Keywords:Non-O1/O139 Vibrio cholerae  Virulence gene  Drug resistance
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《疾病监测》浏览原始摘要信息
点击此处可从《疾病监测》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号